Latest glioblastoma multiforme Stories
First Patient Has Begun Treatment Process; Additional Patients Being Assessed; Waiting List Established BETHESDA, Md., Oct.
SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- DNAtrix, a clinical-stage oncolytic immunotherapy company, announced that it has completed a $20M Series B equity financing.
TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized
- $5.8 million award will help advance the development of oxygen-carrying therapeutics for cancer - SAN CARLOS, Calif., Oct.
DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct.
SAN ANTONIO, Texas, October 9, 2014 /PRNewswire/ -- GenSpera, Inc.
VANCOUVER, British Columbia and MENLO PARK, Calif., Oct.
SAN ANTONIO, Sept. 30, 2014 /PRNewswire/ -- GenSpera, Inc.
Completion of Enrollment Expected in 2015; Progression-Free Survival Data Expected in mid-2016 LOS ANGELES, Sept.
SYDNEY, Sept. 29, 2014 /PRNewswire/ -- Novogen Ltd.
- An imitative word; an onomatopoetic word.